chr9-137048964-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_203468.3(ENTPD2):​c.1261G>C​(p.Gly421Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000217 in 1,381,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000022 ( 0 hom. )

Consequence

ENTPD2
NM_203468.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.35

Publications

0 publications found
Variant links:
Genes affected
ENTPD2 (HGNC:3364): (ectonucleoside triphosphate diphosphohydrolase 2) The protein encoded by this gene is the type 2 enzyme of the ecto-nucleoside triphosphate diphosphohydrolase family (E-NTPDase). E-NTPDases are a family of ecto-nucleosidases that hydrolyze 5'-triphosphates. This ecto-ATPase is an integral membrane protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.034714192).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENTPD2NM_203468.3 linkc.1261G>C p.Gly421Arg missense_variant Exon 8 of 9 ENST00000355097.7 NP_982293.1 Q9Y5L3-1
ENTPD2NM_001246.4 linkc.1192G>C p.Gly398Arg missense_variant Exon 8 of 9 NP_001237.1 Q9Y5L3-2
ENTPD2XM_011519212.3 linkc.952G>C p.Gly318Arg missense_variant Exon 7 of 8 XP_011517514.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENTPD2ENST00000355097.7 linkc.1261G>C p.Gly421Arg missense_variant Exon 8 of 9 1 NM_203468.3 ENSP00000347213.2 Q9Y5L3-1
ENTPD2ENST00000312665.7 linkc.1192G>C p.Gly398Arg missense_variant Exon 8 of 9 1 ENSP00000312494.5 Q9Y5L3-2
ENTPD2ENST00000460614.1 linkn.650G>C non_coding_transcript_exon_variant Exon 1 of 2 1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000311
AC:
4
AN:
128460
AF XY:
0.0000283
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000127
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000210
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000217
AC:
3
AN:
1381466
Hom.:
0
Cov.:
55
AF XY:
0.00000147
AC XY:
1
AN XY:
681334
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30866
American (AMR)
AF:
0.0000577
AC:
2
AN:
34664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24898
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35222
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79014
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5432
European-Non Finnish (NFE)
AF:
9.30e-7
AC:
1
AN:
1075484
Other (OTH)
AF:
0.00
AC:
0
AN:
57488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 10, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1261G>C (p.G421R) alteration is located in exon 8 (coding exon 8) of the ENTPD2 gene. This alteration results from a G to C substitution at nucleotide position 1261, causing the glycine (G) at amino acid position 421 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.017
DANN
Benign
0.63
DEOGEN2
Benign
0.0075
T;.
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.64
T;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.035
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.3
N;.
PhyloP100
-2.4
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.10
N;N
REVEL
Benign
0.032
Sift
Benign
0.29
T;T
Sift4G
Benign
0.20
T;T
Polyphen
0.0030
B;B
Vest4
0.064
MutPred
0.61
Gain of MoRF binding (P = 0.0315);.;
MVP
0.18
MPC
0.064
ClinPred
0.065
T
GERP RS
-6.9
Varity_R
0.090
gMVP
0.57
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1376642191; hg19: chr9-139943416; API